tiprankstipranks
Advertisement
Advertisement

NVAX Stock Latest News

Novavax: COMPARE Study Underscores Safety Edge of Nuvaxovid and Supports Upside from Royalties, Milestones, and Licensing
RatingsNovavax: COMPARE Study Underscores Safety Edge of Nuvaxovid and Supports Upside from Royalties, Milestones, and Licensing
13d ago
NVAX
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
20d ago
DYN
RNA
Novavax price target raised to $18 from $16 at B. Riley
PremiumThe Fly
Novavax price target raised to $18 from $16 at B. Riley
25d ago
NVAX
Novavax call volume above normal and directionally bullish
PremiumThe Fly
Novavax call volume above normal and directionally bullish
2M ago
NVAX
District court rules federal limits to vaccines not based on science, NYT says
PremiumThe Fly
District court rules federal limits to vaccines not based on science, NYT says
2M ago
AZN
BMY
Controversial Prasad leaving FDA, NYT reports
PremiumThe FlyControversial Prasad leaving FDA, NYT reports
2M ago
AZN
BMY
Novavax Earnings Call Signals Leaner, Partner-Led Future
Premium
Company Announcements
Novavax Earnings Call Signals Leaner, Partner-Led Future
2M ago
NVAX
Novavax price target raised to $8 from $7 at BofA
Premium
The Fly
Novavax price target raised to $8 from $7 at BofA
2M ago
NVAX
Novavax price target raised to $7 from $6 at Citi
PremiumThe Fly
Novavax price target raised to $7 from $6 at Citi
2M ago
NVAX
Novavax price target raised to $16 from $11 at H.C. Wainwright
PremiumThe Fly
Novavax price target raised to $16 from $11 at H.C. Wainwright
2M ago
NVAX
Midday Fly By: Nvidia sinks despite blowout guidance
PremiumThe Fly
Midday Fly By: Nvidia sinks despite blowout guidance
2M ago
CRM
EME
Here’s Why Novavax Stock (NVAX) Hit a New 52-Week High on Thursday
PremiumMarket News
Here’s Why Novavax Stock (NVAX) Hit a New 52-Week High on Thursday
2M ago
PFE
SNY
Novavax reports Q4 EPS 11c vs. (51c) last year
PremiumThe FlyNovavax reports Q4 EPS 11c vs. (51c) last year
2M ago
NVAX
Novavax sees FY26 adjusted total revenue $230M-$270M
Premium
The Fly
Novavax sees FY26 adjusted total revenue $230M-$270M
2M ago
NVAX
Options Volatility and Implied Earnings Moves Today, February 26, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, February 26, 2026
2M ago
ZS
BIDU
Novavax price target raised to $8 from $7 at TD Cowen
PremiumThe Fly
Novavax price target raised to $8 from $7 at TD Cowen
2M ago
PFE
NVAX
Is NVAX a Buy, Before Earnings?
PremiumPre-Earnings
Is NVAX a Buy, Before Earnings?
2M ago
NVAX
Options Volatility and Implied Earnings Moves This Week, February 23 – February 26, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, February 23 – February 26, 2026
2M ago
O
AI
Novavax Soars as Traders Bet Big on Vaccine Future
PremiumWeekend Updates
Novavax Soars as Traders Bet Big on Vaccine Future
3M ago
NVAX
Novavax call volume above normal and directionally bullish
PremiumThe FlyNovavax call volume above normal and directionally bullish
3M ago
NVAX
Novavax: Execution Risks, Long-Dated Cash Flows, and COVID Market Headwinds Undermine Profitability Outlook
Premium
Ratings
Novavax: Execution Risks, Long-Dated Cash Flows, and COVID Market Headwinds Undermine Profitability Outlook
3M ago
NVAX
Novavax: Pfizer Partnership Validates Matrix‑M Platform and Supports Upside in Capital‑Light Growth Strategy
Premium
Ratings
Novavax: Pfizer Partnership Validates Matrix‑M Platform and Supports Upside in Capital‑Light Growth Strategy
3M ago
NVAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >